全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

精制清开灵干预缺血性脑损伤药理作用机制研究进展

Keywords: 脑缺血,中风,清开灵注射液,炎症反应,神经营养,血脑屏障

Full-Text   Cite this paper   Add to My Lib

Abstract:

缺血性脑血管病严重威胁人类健康,而且其病理机制非常复杂,涉及兴奋性氨基酸毒性、氧自由基产生、钙超载、炎症反应等多个方面。中药清开灵注射液对脑血管病具有较好的临床疗效,因此对其药理作用机制的研究具有重要意义。该文综述了近年来新型复方中药——精制清开灵注射液治疗脑缺血的药理作用的相关研究,从调节炎症反应、神经营养因子、血脑屏障和血管保护及其他4个方面阐述了其单一有效组分及组分配伍治疗缺血性脑损伤的药理作用机制,为进一步研究提供参考。

 References

[1]  Guo M F, Yu J Z, Ma C G. Mechanisms related to neuron injury and death in cerebral hypoxic ischaemia [J]. Folia Neuropathol, 2011, 49(2): 79.
[2]  Costantino I, Mihaela A. Cerebral ischemia and inflammation [J]. Curr Opin in Neurol, 2001, 14(1): 89.
[3]  Zoppo del G J. Acute anti-inflammatory approaches to ischemic stroke [J]. Ann NY Acad Sci, 2010, 1207: 143.
[4]  Denes A, Thornton P, Rothwell N J, et al. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation [J]. Brain Behav Immun, 2010, 24: 708.
[5]  Arumugam T V, Granger D N, Mattson M P. Stroke and T-cells[J]. Neuromol Med, 2005, 7 (3): 229.
[6]  徐雅,李澎涛,谢利军,等.清开灵不同组分对大鼠MCAO模型脑组织中肿瘤坏死因子的影响特征 [J].中华中医药杂志,2007,22(7):443.
[7]  朱晓磊,张娜,李澎涛,等.胆酸、栀子苷配伍对脑缺血时脑组织TNF-α、IL-1β和ICAM-1含量的影响[J].北京中医药大学学报,2004,27(6):26.
[8]  周峻伟,季绍良,李澎涛.珍珠母、胆酸、栀子苷、黄芩苷对局灶性脑缺血大鼠缺血脑组织单核细胞趋化蛋白的影响[J].中国中医药信息杂志,2004,11(6):500.
[9]  Wang Q, Tang X N, Yenari M A. The inflammatory response in stroke [J]. J Neuroimmunol, 2007, 184(1/2): 53.
[10]  徐丽荣,马世彬,李澎涛,等.清开灵有效组份对局灶性脑缺血大鼠脑组织细胞间黏附分子表达的影响[J].中草药,2004,35(6):666.
[11]  高永红,袁拯忠,牛福玲,等.新清开灵注射液对大鼠脑缺血再灌注损伤微血管内皮细胞黏附分子表达的影响[J].中华中医药杂志,2008,23(3):197.
[12]  高永红,袁拯忠,牛福玲,等.猪胆酸对体外缺血再灌注大鼠脑微血管内皮细胞ICAM-1的影响[J].北京中医药大学学报,2007,30(10):670.
[13]  荆志伟,周才秀,王忠,等. 用主成分分析探索不同中药组分配伍干预脑缺血的基因表达模式[J]. 中医杂志,2010,51(2):164.
[14]  Jung J E, Kim G S, Chen H, et al. Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection [J]. Mol Neurobiol, 2010, 41(2/3): 172.
[15]  Abe K. Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury [J]. J Cerebr Blood F Met, 2000, 20: 1393.
[16]  Terenghi G. Peripheral nerve regeneration and neurotrophic factors [J]. J Anat, 1999, 194: 1.
[17]  钟相根,李澎涛,王永炎,等.清开灵有效组分对大鼠缺血脑组织星形胶质细胞活化的影响 [J].中国医药学报,2004,19(6):338.
[18]  钟相根,李澎涛,王永炎.清开灵有效组分对缺血脑组织神经营养因子含量的影响[J].北京中医药大学学报,2004,27(3):21.
[19]  高永红,王永炎,肖盛元,等.清开灵有效组分透过体外模拟血脑屏障的研究 [J].北京中医药大学学报,2005,28(2):26.
[20]  高永红,牛福玲,朱陵群,等.清开灵有效组分调控大鼠脑MVEC缺血再灌注损伤MMP-9 mRNA表达的研究[J].辽宁中医杂志,2007,34(12):1806.
[21]  朱晓磊,李彭涛.急性缺血性脑卒中后的血管保护策略[J].中国临床康复,2006,10(28):123.
[22]  Iadecola C. Bright and dark sides of nitric oxide in ischemia brain injury [J]. Trends Neurosci, 1997, 20 (3): 132.
[23]  朱晓磊. 精制清开灵抗实验性脑缺血的血管保护机制研究. 北京:北京中医药大学,2006.
[24]  高永红,袁拯忠,牛福玲,等.清开灵有效组分对体外缺血再灌注损伤大鼠脑微血管内皮细胞的保护作用[J].辽宁中医杂志,2008,35(7):1104.
[25]  Mattson M P, Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders[J]. J Clin Invest, 2001, 107 (3): 247.
[26]  高永红,邢雁伟,袁拯忠,等.清开灵有效组分对大鼠脑微血管内皮细胞体外缺血再灌注损伤模型核转录因子-κB的影响[J].中西医结合学报,2009,7(2):135.
[27]  程发峰. 精制清开灵注射液对脑缺血的治疗作用及对兴奋性毒性级联损伤的调控机制. 北京:北京中医药大学,2011.
[28]  周才秀,王忠,荆志伟,等.清开灵有效组分药理通路的多样性分析[J].中国药理学通报,2010,26(4):547.
[29]  Zhao J, Jiang P, Zhang W D. Molecular networks for the study of traditional Chinese medicine pharmacology [J]. Brief Bioinform, 2009, 11(4): 417.
[30]  Mehta S L, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics[J]. Brain Res Rev, 2007, 54(1): 34.
[31]  Hopkins A L. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Boil, 2008, 4(11): 682.
[32]  Chen Y Q, Zhu J, Lum P Y, et al. Variations in DNA elucidate molecular networks that cause disease [J]. Nature, 2008, 452 (7186): 429.
[33]  Berger S I, Iyengar R. Network analyses in systerms pharmacology [J]. Bioinformatics, 2009, 25(19): 2466.
[34]  Hartwell L H, Hopfield J J, Leibler S, et al. From molecular to modular cell biology [J]. Nature, 1999, 402: c47.
[35]  Wu X B, Jiang R, Zhang M Q, et al. Network-based global inference of human disease genes [J]. Mol Syst Biol, 2008, 4: 189.
[36]  Goh K I, Cusick M E, Valle D, et al. The human disease network [J]. Proc Natl Acad USA, 2007, 104(21): 8685.
[37]  Thiagalingam S. A cascade of modules of a network defines cancer progression [J]. Cancer Res, 2006, 66(15): 7379.
[38]  严华,张永祥,黄璐琦,等.清开灵及有效成分对培养大鼠缺血损伤神经胶质细胞分泌NGF的影响[J].中国中医基础医学杂志,2003,9(2):31.
[39]  张占军,李澎,王忠,等.精制清开灵干预MCAO再灌注损伤的药效及机制研究[J].中国病理生理杂志,2006,22(11):2105.
[40]  谢利军,李澎涛,徐雅,等.清开灵有效组分对脑缺血时TGF-β,HSP70含量的影响[J].北京中医药大学学报,2007,30(2):94.
[41]  Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion [J]. Brain Res, 1999, 842(1): 92.
[42]  Chi O Z, Hunter C, Liu X, et al. Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia [J]. Neurochem Res, 2009, 34(7): 1249.
[43]  Fujimoto M, Takagi Y, Aoki T, et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia [J]. J Cerebr Blood F Met, 2008, 28: 1674.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133